155 related articles for article (PubMed ID: 27179695)
1. Estrogen receptor beta modulates breast cancer cells functional properties, signaling and expression of matrix molecules.
Piperigkou Z; Bouris P; Onisto M; Franchi M; Kletsas D; Theocharis AD; Karamanos NK
Matrix Biol; 2016 Dec; 56():4-23. PubMed ID: 27179695
[TBL] [Abstract][Full Text] [Related]
2. Estrogen receptor beta as epigenetic mediator of miR-10b and miR-145 in mammary cancer.
Piperigkou Z; Franchi M; Götte M; Karamanos NK
Matrix Biol; 2017 Dec; 64():94-111. PubMed ID: 28797712
[TBL] [Abstract][Full Text] [Related]
3. Estrogen receptor alpha mediates epithelial to mesenchymal transition, expression of specific matrix effectors and functional properties of breast cancer cells.
Bouris P; Skandalis SS; Piperigkou Z; Afratis N; Karamanou K; Aletras AJ; Moustakas A; Theocharis AD; Karamanos NK
Matrix Biol; 2015 Apr; 43():42-60. PubMed ID: 25728938
[TBL] [Abstract][Full Text] [Related]
4. EGFR is a pivotal player of the E2/ERβ - mediated functional properties, aggressiveness, and stemness in triple-negative breast cancer cells.
Kyriakopoulou K; Kefali E; Piperigkou Z; Riethmüller C; Greve B; Franchi M; Götte M; Karamanos NK
FEBS J; 2022 Mar; 289(6):1552-1574. PubMed ID: 34665934
[TBL] [Abstract][Full Text] [Related]
5. Serglycin promotes breast cancer cell aggressiveness: Induction of epithelial to mesenchymal transition, proteolytic activity and IL-8 signaling.
Bouris P; Manou D; Sopaki-Valalaki A; Kolokotroni A; Moustakas A; Kapoor A; Iozzo RV; Karamanos NK; Theocharis AD
Matrix Biol; 2018 Dec; 74():35-51. PubMed ID: 29842969
[TBL] [Abstract][Full Text] [Related]
6. ΕGFR/ERβ-Mediated Cell Morphology and Invasion Capacity Are Associated with Matrix Culture Substrates in Breast Cancer.
Kyriakopoulou K; Riti E; Piperigkou Z; Koutroumanou Sarri K; Bassiony H; Franchi M; Karamanos NK
Cells; 2020 Oct; 9(10):. PubMed ID: 33050027
[TBL] [Abstract][Full Text] [Related]
7. Expression of estrogen receptor beta increases integrin alpha1 and integrin beta1 levels and enhances adhesion of breast cancer cells.
Lindberg K; Ström A; Lock JG; Gustafsson JA; Haldosén LA; Helguero LA
J Cell Physiol; 2010 Jan; 222(1):156-67. PubMed ID: 19780039
[TBL] [Abstract][Full Text] [Related]
8. Estrogen receptor beta exerts growth-inhibitory effects on human mammary epithelial cells.
Treeck O; Lattrich C; Springwald A; Ortmann O
Breast Cancer Res Treat; 2010 Apr; 120(3):557-65. PubMed ID: 19434490
[TBL] [Abstract][Full Text] [Related]
9. Transcriptional regulation of vascular endothelial growth factor by estradiol and tamoxifen in breast cancer cells: a complex interplay between estrogen receptors alpha and beta.
Buteau-Lozano H; Ancelin M; Lardeux B; Milanini J; Perrot-Applanat M
Cancer Res; 2002 Sep; 62(17):4977-84. PubMed ID: 12208749
[TBL] [Abstract][Full Text] [Related]
10. A laminin-rich basement membrane matrix influences estrogen receptor beta expression and morphology of MDA-MB-231 breast cancer cells.
Neubauer H; Ruoff A; Paessler N; Solomayer E; Wallwiener D; Fehm T
Oncol Rep; 2009 Feb; 21(2):475-81. PubMed ID: 19148525
[TBL] [Abstract][Full Text] [Related]
11. Selective hormone-dependent repression of estrogen receptor beta by a p38-activated ErbB2/ErbB3 pathway.
St-Laurent V; Sanchez M; Charbonneau C; Tremblay A
J Steroid Biochem Mol Biol; 2005 Feb; 94(1-3):23-37. PubMed ID: 15862947
[TBL] [Abstract][Full Text] [Related]
12. Lumican effectively regulates the estrogen receptors-associated functional properties of breast cancer cells, expression of matrix effectors and epithelial-to-mesenchymal transition.
Karamanou K; Franchi M; Piperigkou Z; Perreau C; Maquart FX; Vynios DH; Brézillon S
Sci Rep; 2017 Mar; 7():45138. PubMed ID: 28332606
[TBL] [Abstract][Full Text] [Related]
13. The action of hyaluronan in functional properties, morphology and expression of matrix effectors in mammary cancer cells depends on its molecular size.
Tavianatou AG; Piperigkou Z; Koutsakis C; Barbera C; Beninatto R; Franchi M; Karamanos NK
FEBS J; 2021 Jul; 288(14):4291-4310. PubMed ID: 33512780
[TBL] [Abstract][Full Text] [Related]
14. Estrogen receptor beta growth-inhibitory effects are repressed through activation of MAPK and PI3K signalling in mammary epithelial and breast cancer cells.
Cotrim CZ; Fabris V; Doria ML; Lindberg K; Gustafsson JÅ; Amado F; Lanari C; Helguero LA
Oncogene; 2013 May; 32(19):2390-402. PubMed ID: 22751110
[TBL] [Abstract][Full Text] [Related]
15. Benzopyran derivative CDRI-85/287 induces G2-M arrest in estrogen receptor-positive breast cancer cells via modulation of estrogen receptors α- and β-mediated signaling, in parallel to EGFR signaling and suppresses the growth of tumor xenograft.
Saxena R; Fatima I; Chandra V; Blesson CS; Kharkwal G; Hussain MK; Hajela K; Roy BG; Dwivedi A
Steroids; 2013 Nov; 78(11):1071-86. PubMed ID: 23891847
[TBL] [Abstract][Full Text] [Related]
16. Oestrogen receptors pathways to oestrogen responsive elements: the transactivation function-1 acts as the keystone of oestrogen receptor (ER)beta-mediated transcriptional repression of ERalpha.
Gougelet A; Mueller SO; Korach KS; Renoir JM
J Steroid Biochem Mol Biol; 2007 May; 104(3-5):110-22. PubMed ID: 17478088
[TBL] [Abstract][Full Text] [Related]
17. Impact of estrogen receptor beta on gene networks regulated by estrogen receptor alpha in breast cancer cells.
Chang EC; Frasor J; Komm B; Katzenellenbogen BS
Endocrinology; 2006 Oct; 147(10):4831-42. PubMed ID: 16809442
[TBL] [Abstract][Full Text] [Related]
18. Agonists and knockdown of estrogen receptor β differentially affect invasion of triple-negative breast cancer cells in vitro.
Schüler-Toprak S; Häring J; Inwald EC; Moehle C; Ortmann O; Treeck O
BMC Cancer; 2016 Dec; 16(1):951. PubMed ID: 28003019
[TBL] [Abstract][Full Text] [Related]
19. Sulfated Hyaluronan Modulates the Functional Properties and Matrix Effectors Expression of Breast Cancer Cells with Different Estrogen Receptor Status.
Koutsakis C; Tavianatou AG; Kokoretsis D; Baroutas G; Karamanos NK
Biomolecules; 2021 Dec; 11(12):. PubMed ID: 34944559
[TBL] [Abstract][Full Text] [Related]
20. Indole-3-carbinol selectively uncouples expression and activity of estrogen receptor subtypes in human breast cancer cells.
Sundar SN; Kerekatte V; Equinozio CN; Doan VB; Bjeldanes LF; Firestone GL
Mol Endocrinol; 2006 Dec; 20(12):3070-82. PubMed ID: 16901971
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
